Microbot Medical Inc. (MBOT) |
|
1.39 0.06 (4.51%)
|
09-29 16:00 |
|
Open: |
1.34 |
Pre. Close: |
1.33 |
|
High:
|
1.4599 |
Low:
|
1.33 |
|
Volume:
|
79,319 |
Market Cap:
|
16(M) |
|
|
|
Technical analysis |
as of: 2023-09-29 4:28:55 PM |
|
Short-term rate:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 2.22 One year: 2.69 |
| Support: |
Support1: 1.25 Support2: 1.04 |
| Resistance: |
Resistance1: 1.9 Resistance2: 2.3 |
| Pivot: |
1.67  |
| Moving Average: |
MA(5): 1.34 MA(20): 1.78
MA(100): 2.2 MA(250): 2.82 |
| MACD: |
MACD(12,26): -0.3 Signal(9): -0.2 |
| Stochastic oscillator: |
%K(14,3): 8.7 %D(3): 8.1 |
| RSI: |
RSI(14): 30.2 |
| 52-week: |
High: 5.5 Low: 1 |
| Average Vol(K): |
3-Month: 125 (K) 10-Days: 166 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ MBOT ] has closed above bottom band by 30.7%. Bollinger Bands are 52.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.46 - 1.47 |
1.47 - 1.47 |
|
Low:
|
1.32 - 1.32 |
1.32 - 1.33 |
|
Close:
|
1.38 - 1.39 |
1.39 - 1.4 |
|
Company Description |
|
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts. |
Headline News |
Thu, 28 Sep 2023
Axcella Health Inc NASDAQ AXLA Bounces Back with a 781 ... - Best Stocks
Thu, 28 Sep 2023
NASDAQ Halts Trading with Assurance of Prompt Resumption - Best Stocks
Thu, 28 Sep 2023
Microbot Medical Engages CRO to Support its Upcoming U.S. ... - BioSpace
Wed, 20 Sep 2023
Thinking about buying stock in P3 Health Partners, Joby Aviation ... - Marketscreener.com
Wed, 20 Sep 2023
Microbot Medical Inc (MBOT) has gained 4.88% Wednesday In Premarket Trading - InvestorsObserver
Mon, 18 Sep 2023
Healthcare Stocks Moving Monday: AVGR, SQL, CABA, SIEN, CARA, MBOT, PIII, LZAGY - InvestorsObserver
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Outperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Outperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Instruments & Supplies |
| Shares Out. |
12 (M) |
| Shares Float |
11 (M) |
|
% Held by Insiders
|
2 (%) |
|
% Held by Institutions
|
19.3 (%) |
|
Shares Short
|
144 (K) |
|
Shares Short P.Month
|
223 (K) |
Stock Financials |
|
EPS
|
-1.45 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0.81 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
0 |
|
Return on Assets (ttm)
|
-68.8 |
|
Return on Equity (ttm)
|
-128.9 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
-1 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-10 (M) |
|
Levered Free Cash Flow
|
-6 (M) |
Stock Valuations |
|
PE Ratio
|
-0.97 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
1.71 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
-1.56 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
